- Neuberger Berman has marked down investments in Pine Labs and PharmEasy.
- This is due to the chill in the consumer Internet investment ecosystem and the subsequent cooling down in startups’ growth in India.
- The markdowns are being made by US institutional investors of their investments in late-stage companies.
